Kidney Diseases Clinical Trials

191 recruitingLast updated: June 17, 2026

There are 191 actively recruiting kidney diseases clinical trials across 51 countries. Studies span Not Applicable, Phase 2, Phase 4, Phase 3, Phase 1, Early Phase 1. Top locations include New York, New York, United States, Dallas, Texas, United States, Beijing, Beijing Municipality, China. Updated daily from ClinicalTrials.gov.


Kidney Diseases Trials at a Glance

191 actively recruiting trials for kidney diseases are listed on ClinicalTrialsFinder across 6 cities in 51 countries. The largest study group is Not Applicable with 65 trials, with the heaviest enrollment activity in New York, Dallas, and Beijing. Lead sponsors running kidney diseases studies include Brigham and Women's Hospital, Chinese University of Hong Kong, and Emory University.

Browse kidney diseases trials by phase

Treatments under study

About Kidney Diseases Clinical Trials

Looking for clinical trials for Kidney Diseases? There are currently 43 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Kidney Diseases trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Kidney Diseases clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 191 trials

Recruiting

Precision Medicine Approaches to Renal Osteodystrophy

Chronic Kidney DiseasesCkd-MbdSecondary Hyperparathyroidism+2 more
Thomas Nickolas40 enrolled1 locationNCT05880914
Recruiting
Phase 2

Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus

Chronic Kidney DiseasesPruritus
Vifor Fresenius Medical Care Renal Pharma18 enrolled16 locationsNCT06593392
Recruiting
Not Applicable

Theory-based Health Behaviour Change Intervention in Patients of Metabolic Syndrome With Chronic Kidney Disease

Metabolic SyndromeChronic Kidney Diseases
Chinese University of Hong Kong40 enrolled1 locationNCT06527768
Recruiting
Not Applicable

Theory-based Health Behaviour Change Intervention in Individuals of Metabolic Syndrome With Chronic Kidney Disease

Metabolic SyndromeChronic Kidney Diseases
Chinese University of Hong Kong160 enrolled1 locationNCT06715735
Recruiting
Phase 2

PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease

Proteinuric Kidney Diseases
Boehringer Ingelheim132 enrolled156 locationsNCT07355296
Recruiting
Phase 2

Safety of RotigotiNe in Patients With Autosomal Dominant Polycystic Kidney Disease

Kidney Diseases
University Hospital, Rouen120 enrolled4 locationsNCT06291116
Recruiting
Phase 4

Comparison of the Effects of Belatacept and Anticalcineurins on Endothelial Function in Renal Transplant Patients - <BELAFENDO>

Kidney Diseases
University Hospital, Rouen44 enrolled1 locationNCT06291077
Recruiting
Not Applicable

Collaborative Learning to Achieve Refined Interventions for Emory: Kidney Disease

Kidney Diseases
Emory University600 enrolled2 locationsNCT06693661
Recruiting

Impact of Trans-catheter Aortic Valve Implantation on Renal Function

Chronic Kidney DiseasesAortic Valve StenosisRenal Failure Acute Chronic
Fondazione Policlinico Universitario Agostino Gemelli IRCCS1,000 enrolled1 locationNCT07626710
Recruiting
Phase 2

A Study of the Safety and Activity of Sparsentan for the Treatment of Patients With Immunoglobulin A Nephropathy

Kidney DiseasesImmune System DiseasesAutoimmune Diseases+3 more
University of Leicester24 enrolled6 locationsNCT04663204
Recruiting
Phase 3

Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.

Kidney DiseasesKidney Diseases, ChronicUrological Diseases+5 more
Novartis Pharmaceuticals220 enrolled18 locationsNCT06858319
Recruiting
Phase 3

Bleeding Reduction in Acute and Chronic Kidney Patients Having Surgery (BRACKETS) Pilot Trial

SurgeryChronic Kidney DiseasesAcute Kidney Injury+1 more
Hamilton Health Sciences Corporation100 enrolled3 locationsNCT06337838
Recruiting

American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study)

Diabetes MellitusCardiovascular DiseasesChronic Kidney Diseases+1 more
University of New Mexico500 enrolled3 locationsNCT04185844
Recruiting
Not Applicable

Beetroot Extract Supplementation Associated With an Exercise Protocol for Chronic Kidney Disease Patients

Chronic Kidney Diseases
Universidade Federal Fluminense25 enrolled1 locationNCT06286748
Recruiting
Not Applicable

Green Propolis Extract and Royal Jelly in Hypertensive Patients and/or With Chronic Kidney Disease

Cardiovascular DiseasesHypertensionChronic Kidney Diseases
Universidade Federal Fluminense153 enrolled2 locationsNCT06288204
Recruiting
Not Applicable

SPYRAL GEMINI Pilot Study

Diabetes MellitusCardiovascular DiseasesHypertension+2 more
Medtronic Vascular175 enrolled16 locationsNCT06907147
Recruiting
Phase 2

Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD

Insulin ResistanceChronic Kidney DiseasesFatigue+4 more
University of California, Davis80 enrolled2 locationsNCT04984226
Recruiting
Not Applicable

Supporting VETerans With Kidney Disease Through Food As Medicine

HypertensionDiabetesKidney Diseases+1 more
VA Eastern Colorado Health Care System20 enrolled1 locationNCT07194733
Recruiting
Not Applicable

Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension

Diabetes MellitusCardiovascular DiseasesHypertension+2 more
Medtronic Vascular130 enrolled19 locationsNCT07115953
Recruiting
Phase 4

Dapagliflozin on Renal Morphology and Renal Perfusion in Patients One Year After Kidney Transplantation

Chronic Kidney Diseases
University of Erlangen-Nürnberg Medical School48 enrolled1 locationNCT06560801